Skip to main content
OpenTrials
Completed

NCT Number: NCT00700687

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Anaheim, California, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male or non-pregnant female subjects greater than or equal to 50 years as well as other standard inclusion criteria for a study of this nature

Exclusion criteria

  • Standard exclusion criteria for a study of this nature

Treatment and study plan

PA32540

Drug

aspirin/omeprazole

PA32540 and celecoxib

Drug

aspirin/omeprazole and celecoxib

aspirin and [NSAID]

Drug

aspirin and [NSAID]

Primary outcomes

  1. Lanza scores

    Time frame: entire course of study

Secondary outcomes

  1. safety of three treatments

    Time frame: entrie course of study

Sponsors and collaborators

Lead sponsor

POZEN

Industry

Registry information

Acronym: PA32540-109

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Jun 19, 2008
Registry last updated
Jan 12, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.